Clinical Trial Update: A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

View source ↗

Summary

This update outlines a non-interventional, post-authorization safety study of patients treated with efgartigimod alfa for myasthenia gravis, with recruitment on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Efgartigimod alfa (efgartigimod alfa)

Snippet

Sponsor: argenx | Conditions: Myasthenia Gravis | Status: RECRUITING